Using lithium as a neuroprotective agent in patients with cancer
Version 3 2024-06-20, 01:19
Version 2 2024-05-30, 15:36
Version 1 2012-11-02, 00:00
journal contribution
posted on 2024-06-20, 01:19 authored by M Khasraw, D Ashley, G Wheeler, Michael BerkMichael BerkUsing lithium as a neuroprotective agent in patients with cancer
History
Related Materials
- 1.
Location
EnglandOpen access
- Yes
Language
EnglishNotes
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Publication classification
C1 Refereed article in a scholarly journalCopyright notice
2012, Khasraw et al.Journal
BMC MedicineVolume
10Article number
ARTN 131Pagination
1 - 7ISSN
1741-7015eISSN
1741-7015Issue
1Publisher
BMCPublication URL
Usage metrics
Categories
No categories selectedKeywords
Science & TechnologyLife Sciences & BiomedicineMedicine, General & InternalGeneral & Internal MedicineGLUTAMATE-RECEPTOR SUPERSENSITIVITYHIPPOCAMPAL NEUROGENESISBREAST-CANCERRADIATION-THERAPYSTEM-CELLCOGNITIVE FUNCTIONSYNTHASE KINASE-3BRAINIRRADIATIONSURVIVORS110999 Neurosciences not elsewhere classified970111 Expanding Knowledge in the Medical and Health Sciences
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC